A Co-CEO of a leading neurotherapeutics developer reported significant insider selling amid a year of standout stock ...
As the U.S. backpedals on its mRNA investment, Mexico is embracing the technology through a new manufacturing pact with ...
Piramal Pharma Limited (PPL), (NSE: PPLPHARMA) (BSE: 543635), offers a portfolio of differentiated products and services through its 17 1 global development and manufacturing facilities and a global ...
An enterprise AI platform bringing decision-grade intelligence to regulated pharmaceutical operations This partnership ...
OpenLoop, a company providing operational and tech services to telehealth companies, and compounding pharmacy Triad Rx are being sued in a class action for selling oral tirzepatide. | The complaint ...
The move drew skepticism from investors despite multiple recent research setbacks that have left questions about Sanofi’s ...
Welcome to Fierce Pharma's regulatory tracker for the first half of 2026. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new ...
Jan 30 (Reuters) - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on imported branded and patented medicines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results